Sunho Biologics,Inc. (2898) Stock Statistics & Valuation Metrics

Sunho Biologics,Inc. has a market cap or net worth of HK$970.43M. The enterprise value is HK$780.95M.

Sunho Biologics,Inc. has 156,666,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sunho Biologics,Inc.’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -18.32%.

The current PE Ratio of Sunho Biologics,Inc. is ―. Sunho Biologics,Inc.’s PEG ratio is 0.10.

In the last 12 months, Sunho Biologics,Inc. had revenue of 38.00K and earned -79.97M in profits. Earnings per share was -0.62.

In the last 12 months, operating cash flow was 11.18M and capital expenditures -34.24M, giving a free cash flow of -23.07M billion.

Sunho Biologics,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Sunho Biologics,Inc. upcoming earnings date is Aug 29, 2025, Before Open (Confirmed).

Sunho Biologics,Inc. as a current ratio of 11.17, with Debt / Equity ratio of 14.18%

In the past 12 months, Sunho Biologics,Inc. has paid 0.00 in taxes.

Sunho Biologics,Inc. EV to EBITDA ratio is -4.40, with an EV/FCF ratio of -2.64.

Sunho Biologics,Inc. has HK$441.40M in cash and marketable securities with HK$68.24M in debt, giving a net cash position of HK$373.16M billion.

Gross margin is 100.00%, with operating margin of -266723.68%, and net profit margin of -210434.21%.

The average price target for Sunho Biologics,Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―